Navigation Links
New strategy rapidly identifies cancer targets

In a step toward personalized medicine, Howard Hughes Medical Institute investigator Brian J. Druker and colleagues have developed a new technique to identify previously unknown genetic mutations that can trigger cancerous growth. By analyzing the proteins ?instead of the genes ?inside acute myeloid leukemia (AML) cells, the researchers have dramatically reduced the time it takes to zero in on molecular abnormalities that might be vulnerable to specific drug treatments.

"This approach gives us a way to figure out what's driving the growth of a cancer in an individual patient and ultimately match that patient with the right drug," said Druker, who is based at the Oregon Health & Science University in Portland. Druker's team collaborated on the research, which was published in the July 17, 2006, issue of the journal Cancer Cell, with scientists in the lab of D. Gary Gilliland, an HHMI investigator at Brigham and Women's Hospital, as well as researchers at the Portland VA Medical Center, Cell Signaling Technology, the University of Chicago, and Yale University.

Traditionally, cancer-gene hunters have scanned the genome looking for mutations that trigger out-of-control cell growth. Druker tried this approach, but found it wanting. "We were doing some high-throughput DNA sequencing, and we weren't really finding much," he said.

Instead, the team added tools from the burgeoning field of proteomics, the study of proteins. "We decided this more functional assay would get us to the disease-causing genes more rapidly," said Druker, who has been studying a group of cell-signaling proteins called tyrosine kinases for 20 years.

Tyrosine kinases play a key role in many cancers. In healthy cells, they help form a chain of signals that prompt normal cell growth and division. Sometimes, though, a tyrosine kinase gets stuck in an "on" position, driving out-of-control cell division and, ultimately, cancer. This potentially devastating
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3

Related biology news :

1. Gene silencing technique offers new strategy for treating, curing disease
2. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
3. Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect
4. Melanoma vaccine strategy shows promise in laboratory experiments
5. Study by Einstein researchers could lead to a novel strategy for treating obesity
6. Team discovers possible universal strategy to combat addiction
7. Researchers discover way to transport environmental arsenic to plant leaves in new clean-up strategy
8. Attacking cancers sweet tooth is effective strategy against tumors
9. Researchers unveil strategy for creating actively-programmed anti-cancer molecules
10. New strategy developed to combat West Nile Virus
11. Circumcision: A proven strategy to prevent HIV

Post Your Comments:
(Date:12/2/2009)...REDWOOD SHORES, Calif. and PALM HARBOR, Fla., Dec....gence Corporation ("CIC") (OTC Bulletin Board: CIC...utions for business process automation in the fina...metric signature verification and Docubase Systems...onic Document Management (EDM) software provider a...
(Date:12/2/2009)... student at the University of Southampton,s School... Oceanography Centre, Southampton (NOCS) has forma...rom the deep sea. , Hall discovered the new spec... Museum of Natural History in Washington. Explaini...rabs include some of the largest crustaceans curre...
(Date:12/1/2009)...VALE, Calif., Dec. 1 GestureTek In... 3.0 - a turnkey, portable, plug and play interact...ibits, entertainment and touring promotions. Gestu...nts in camera-enabled gesture recognition technolo...tainment systems. ,, Guaranteed for quality, th...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4King crab family bigger than ever 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Cadient Group Selected as Finalist in Medical Marketing 26 Media Awards 14180 1Cadient Group Selected as Finalist in Medical Marketing 26 Media Awards 14180 2Experimental drug lets B cells live and lymphoma cells die 57777 1Experimental drug lets B cells live and lymphoma cells die 57777 2Experimental drug lets B cells live and lymphoma cells die 57777 3Experimental drug lets B cells live and lymphoma cells die 57777 4Pediatrics 3A Kids need specialized care in hospital emergency departments 57775 1
... Oct. 4, 2007 A new Oak Ridge National Laboratory...e, Mississippi and South Carolina and also lead to... Community and Regional Resilience Initiative (CAR...s, and Charleston, S.C., to increase resilience t...recover from natural and man-made disasters of th...
... Nearly three-quarters of Americans are willing to...ocal government-led initiatives designed to reduce...survey conducted by GfK Public Affairs and the Yal...City and local leaders are critical players in the...at their constituents want action, said Anthony L...
...e the form of tiny grains resembling powder, which...me, researchers from the European Synchrotron Radi...echerche Scientifique used X-ray diffraction at th...rystal grains of one cubic micrometre. They gained...ble samples, opening up new research possibilities...
Other Biology News:ORNL 'resilience' plan to help Tennessee, Mississippi and South Carolina communities beat disaster 2Majority of Americans want local action on global warming, says poll 2Unveiling the structure of microcrystals 2
(Date:12/2/2009)...I, Dec. 2 /PRNewswire-Asia/ -- The world is going ...l and uncertainty is part of many,businesses and i...as been,relatively immune to the economic downturn... During the midst of the difficult times this y...n inaugurated an R&D center in Shanghai, the l...
(Date:12/1/2009)..., Nev., Dec. 1 PDL BioPh...revenue guidance for the fourth quarter ended Dece...pared with $69 million for the fourth quarter of 2...he first of two installment payments of $12.5 mill... 2008 results was a one-time $1.8 million payment ...
(Date:12/1/2009)...., Dec. 1 Harvest Technologies Cor... from the company sponsored 60-patient clinical tr... Chennai, India using the company,s BMAC System to...Limb Ischemia (CLI). Sri Ramachandra Medical Cente...stitution based in Chennai, India and one of the l...
(Date:12/1/2009)...a., Dec. 1 Expanding its European ...nc. of Sarasota has appointed Lake Chemicals and M...s located near Birmingham, England. ,, Osprey ...e the agricultural, waste water, and environmental...o open drain fields, and clean up industrial and m...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...Answer Questions about Attention Deficit Hyperacti...NEW YORK, Sept. 12 The 10th annual ,ADHD Experts ...tember 17, 2008, from 8 a.m.,to midnight EDT to pr...ention Deficit Hyperactivity Disorder (ADHD), as w...sk questions and learn more about ADHD from,expert...
...f., Sept. 12 Bionovo, Inc.,(Nasdaq: BNVI ), a ph...development of safe and effective drugs in the are...hat Dr. Isaac Cohen, Chairman and CEO, and Dr.,Mar... of Bionovo, will be,presenting at the Merriman Cu...r 15, 2008 at 2:15 p.m. This event will be held at...
...a., Sept. 12 Catalyst,Pharmaceutical Partners, In...hat acquires, in-licenses, develops and commercial...addiction and obsessive compulsive disorders,today...eements with,institutional investors to sell 1,488...0 per share in a registered direct common stock of...
Other Biology Technology:Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 2Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 3Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 4Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 5Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 6Bionovo to Present at Merriman Curhan Ford's Investor Summit 2008 on September 15th 2Bionovo to Present at Merriman Curhan Ford's Investor Summit 2008 on September 15th 3Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering 2Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering 3
...ated multifunction centrifuges are equally capable...und level with a large range of rotors and accesso... rotor exchange system without tools ensures that .... Instant rotor exchange (5 sec.) with AUTO-LO...
X-Gal from ABgene
...cco Etch Virus (TEV) protease that is highly site-...able than native TEV protease, resulting in long-t...es a seven amino acid (Glu-Asn-Leu-Tyr-Phe-Gln-Gly...for removing affinity tags from fusion proteins (1...
Rabbit Anti-Versican (H-56) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: